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IN MANY TRANSPLANTATION CENTERS, it has been 
considered obligatory to remove failed renal homo-
grafts before, or at, retransplantation, since such 
grafts have been regarded as a potential hazard 
to the patient. At our institution, this routine has, 
in the last years, been applied only to grafts which 
failed in the immediate postoperative period and 
which, consequently, were considered infarcted. 
In contrast, grafts which have failed late from 
chronic rejection have been left in situ. In the pres-
ent study, the fate of such retained, nonfunctioning 
or poorly functioning grafts was evaluated. 
METHODS 
Twenty-eight patients who had chronically re-
jected, or otherwise failed, renal homografts left 
in situ were studied. Eleven of these patients were 
females and 17 males; their ages ranged from three 
and a half to 45 years. Twenty-one patients had 
only one retransplantation, four received three 
grafts; two had four, and one patient had five kidney 
transplants. In no instance did any patient carry 
more than two grafts at one time. The total num-
ber of retained grafts at risk was 30. Retransplanta-
tion was carried out one month to six and a half 
years after the insertion of the previous graft, a 
mean of 33 months. 
Twelve of the patients underwent hemodialysis 
before retransplantation, while the others were 
provided with new grafts before this became neces-
sary. About two-thirds of the retained previous 
homografts were from related donors; the others 
were from nonrelated cadavers. Most of these 
grafts were located extra peritoneally in the pelvis, 
but four had been placed intra-abdominally be-
cause the recipients were children (1). 
Immunosuppression was either with the double 
drug combination of azathioprine and prednisone 
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or with a triple drug regimen consisting of azathio-
prine or cyclophosphamide, prednisone, and anti-
lymphocyte globulin (2, 3). 
Evaluation of the graft was by physical examina-
tion, standard renal function tests, and intravenous 
pyelograms. In several instances, technetium 
(99mTc-pertechnetate) or mercury (197Hg-chlor-
merodrin) radioisotope scans were obtained. 
RESULTS 
Fourteen patients died five days to 21 months 
after retransplant at ion, a mean of six months. In 
each patient but one, the fatal outcome apparently 
was unrelated to the retained previous homograft. 
At autopsy, the original grafts showed various de-
grees of rejection and fibrosis. In the one excep-
tional instance, the retained previous graft was 
totally necrotic and infected at postmortem exami-
nation. This patient was a 13 year old girl in whom 
an intraabdominal, poorly functioning, cadaveric 
graft was left in situ after implantation of a ma-
ternal kidney. Two and a half months after the 
latter transplantation, Escherichia coli septicemia 
developed and she died. At autopsy, the infected 
cadaveric graft grew out the same bacteria. There 
had been no local symptoms from the necrotic kid-
ney. 
In the 14 surviving patients, the follow-up time 
since retransplantation ranges from four to 34 
months, a mean of 17 months. According to clinical 
criteria, the cause of failure of the previous grafts 
was rejection in all instances. In three of the sur-
viving patients, symptoms developed from the re-
tained previous grafts 13, 20, and 21 months after 
retransplantation. All three patients complained 
of pain and tenderness at the graft site. One pa-
tient had a sudden occurrence of large numbers of 
leukocytes in the urine; the other two had a normal 
urinalysis. Two of the patients had a low grade 
fever. 
Renal scans showed no uptake of radioisotope 
at the site of the retained old graft (Fig. 1). In one 
patient, there was a sudden disappearance in excre-
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FIG. 1. Mercury radioisotope renal scan in a patient with retransplantation in 
whom pain and tenderness developed above the right side of the groin, where a 
poorly functioning first homograft had been left in situ. The second graft on the 
left side shows normal uptake; the first graft cannot be visualized. On removal, 
the old graft was found to be partially infarcted. 
tlOn of radiographic contrast media. After nephrec-
tomy, the patients were relieved of the symptoms, 
and there were no postoperative complications. 
Another three patients had nonfunctioning pre-
vious grafts removed, one, one, and two months 
after retransplantation. In two instances, the de-
cision for nephrectomy was arbitrary. In the third 
patient, the graft was removed because it was 
feared to be a cause of hypertension. Postopera-
tively, the arterial blood pressure of the patient 
decreased. 
In three patients who underwent retransplanta-
tion because the first grafts had failed, presumably 
because of rejection after one, three, and 25 months, 
the function of the original grafts appeared to im-
prove. At the time of retransplantation, the first 
grafts had not showed excretion of radiographic 
contrast media, but later, they showed sufIicient 
concentration to reveal good quality pyelograms 
bilaterally (Fig. 2). 
DISCUSSION 
It has been customary to excise grafts which fail 
after months or years of function, mainly because 
of the fear that such nonfunctioning grafts could 
become necrotic and infected. The findings in the 
present study indicate that such events can indeed 
take place. In three patients, grafts that were still 
providing life-sustaining function at the time of 
retransplantation underwent partial necrosis many 
months later. The most significant symptoms were 
local pain and tenderness. The diagnosis of infarc-
tion was supported by the disappearance of isotope 
uptake in the graft. These grafts were removed 
before they caused harm to the host. However, the 
potential danger of omitting removal of such 
necrotic grafts was illustrated by the course in the 
FIG .. 2. Intravenous pyelogram of a patient in whom re-
transplantation was done with a cadaveric graft-left side-
three months after the receipt of a maternal graft-right 
side. At the time of the retransplantation, the first graft had 
ceased to function, presumably due to rejection. Five and 
a half months later when this pyelogram was obtained, 
there was excellent visualization of both grafts. 
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child in whom an intra-abdominal failed graft 
became the unrecognized focus of a lethal infection. 
The intra-abdominal location of the graft pre-
vented the expression of local symptoms with sub-
sequent failure to diagnose and treat the condition. 
Arterial hypertension, pronounced proteinuria, 
or persistent urinary tract infection also might 
justify removal of a previous graft. In the presently 
reported patients, nephrectomy was carried out 
for such an indication only in one instance. 
In spite of the aforementioned valid reasons for 
homograft nephrectomy, we have had an increas-
ing tendency to leave homografts in place, unless 
there is a specific indication for their removal. In 
part, this has resulted from a subtle change in our 
attitude about the proper timing of retransplanta-
tion. Increasingly, retransplantation has been 
carried out before complete renal homograft fail-
ure and before the necessity of returning the pa-
tient to dialysis. In such recipients, the remaining 
function of the old graft has been depended upon 
prior to retransplantation, and, afterward, it has 
sometimes been crucial during ,a temporary period 
of acute tubular necrosis or severe, early rejection 
of the new kidney. 
I t is of interest that at least three retained homo-
grafts which had been judged as having failed due 
to rejection resumed some function after the re-
transplantation. The high prednisone dosages given 
over the first month after retransplantation prob-
ably accounted for this favorable change, although 
conceivably the reappearance of a good quality 
pyelogram may have been due to relief of azotemia, 
as has sometimes been described after hemodialysis. 
SUMMARY 
The fate of nonfunctioning or poorly functioning 
renal homografts which were left in situ at retrans-
plantation was studied in 28 patients. In one recipi-
ent, lethal septicemia developed secondary to 
necrosis as well as infection of a retained intra-
abdominal graft. In three other patients, subse-
quent symptoms developed from retained extra-
peritoneal pelvic grafts, and these kidneys were 
removed without complication. It is suggested that 
grafts placed extraperitoneally can be left in place 
if retransplantation becomes necessary, provided 
that there is careful follow-up study for signs of 
necrosis or infection. Removal of the kidney graft 
then may be performed electively at a later time, or 
this may never become necessary in a significant 
number of patients. 
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